Online Health Tips

Introducing Effective Alternative for High Cholesterol

(PRWEB) September 10, 2004

HERBALmax™ (http://www.herbal-max.com ) introduces CHOLESTEROL Formula to help reduce high cholesterol. It is specially designed to focus on the cleansing of the coronary artery. It helps metabolize cholesterol and blood lipid, maintain a healthy heart and lose weight.

A unique formula from other cholesterol herbals, CHOLESTEROL Formula promotes artery cleansing, helps with lowering cholesterol levels and promotes a healthy heart. Because it helps to rid cholesterol and lipids (fats), taken overtime, it promotes weight loss. It improves the heart function and, as a result, improves exercise capacity and tolerance.*

Cholesterol at high levels is very dangerous; it leads to heart disease-America’s number one killer. High cholesterol deposits along the inner lining of the arteries, a condition known as atherosclerosis. This build-up narrows the blood vessels, eventually leading to heart attacks and strokes. According to the American Heart Association, an estimated 104.7 million American adults have borderline-high risk cholesterol levels, of which 37 million are high risk.

Cholesterol levels are affected strongly by eating foods high in saturated fats, and foods containing high levels of cholesterol like eggs, red meat, lard and shrimp. Men have higher risk of heart disease from cholesterol than women. The average American man exceeds the recommended daily cholesterol intake by 20%.*

Ms Geselowitz, a musician says, “I have genetic cholesterol problems, when my cholesterol level reached 237, I was so worried.” She adds, “After I took the HERBALmax™ CHOLESTEROL formula for a few weeks, my cholesterol level dropped to 178.”

Several types of drugs used to treat high cholesterol include Lipitor (Atorvastatin), Zocor and Mevacor. These drugs lower cholesterol by working within the liver. The decision to take drugs for lowering high cholesterol is not taken lightly by doctors. Drugs can run fairly expensive and are usually required for many years or for life with the risk of dangerous side effects such as damage to the liver.

HERBALmax™ CHOLESTEROL Formula works directly on the coronary artery to improve heart function and contains herbs known to improve liver effectiveness. CHOLESTEROL Formula has no side effects. It is available in the U.S. at $ 38.95 for 270 capsules at http://www.herbal-max.com or by phone at 310-234-9689.

Dr. Zhang is the creator of HERBALmax™. She has spent over 20 years in research and clinical practice developing her formulas. In China, Dr. Zhang is a highly regarded scientist who specialized in herbal pharmacology and traditional Chinese medicine at one of the premiere Traditional Chinese Medical Universities.

She has authored over 30 scientific articles and two books. Her comprehensive textbook, Complete Guide for Identifying and Characterizing Chinese Herbals, was named one of the best scientific books by the Chinese Government in 1992.

Dr. Zhang received First Prize for her research from the Chinese government in 1992. In 1994, she won Best Paper Award from the First World Traditional Medicine Conference in the U.S.

HERBALmax™ has other products for heart, skin allergies, blood pressure, acne, impotence, flu, cough, depression and chronic fatigue, and menopause. If you wish to learn more about these herbal products, visit http://www.herbal-max.com .

Data from American Heart Association

Dharmananda, Subhuti, Ph.D., “Hawthorn (Crataegus): Food and Medicine In China” Institute of Traditional Medicine. Jan 2004.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, cure or prevent any disease.

# # #

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

New Fiction Book Released by Author Rick Goeld

New Fiction Book – Sex, Lies, and Soybeans by Rick Goeld

Scottsdale, AZ (Vocus) October 19, 2010

A new fiction book has been released by author Rick Goeld. His new novel, Sex, Lies, and Soybeans, asks: “What happens when we become too dependent on genetically engineered food?”

The story takes place in a near-future where bird flu, swine flu, mad cow, red tide, and other diseases have decimated virtually every source of animal protein. Soy has become the world’s “go to” crop for protein, and the soy industry has become the world’s most powerful food consortium. Their long-term goal: dominate the worldwide food market with genetically engineered synthetic food made with 100% soy. Their interim goal: saturate the American fast-food market. Texas is their first target. If they can conquer the influential state of Texas, other states will fall like dominoes.

But Victoria Blackburn, Chairman of the Texas State Senate’s Food and Drug Committee, is blocking key soy-industry-sponsored legislation. Lobbyist’s attempts to influence her are unsuccessful, so Plan B is devised: penetrate her family and twist a few arms—or worse—to change the Senator’s mind. Her brother, William, a slacker with an overactive sex drive, is identified as the “weak link” in the family.

“When I started this novel back in 2004,” Goeld said, “much of the discussion was about genetically engineered soy, corn, and wheat. Today, genetically engineered salmon is the hot-button issue.” Goeld was referring to last month’s recommendation by an advisory committee to the FDA that genetically engineered salmon would be safe to eat and for the environment (“Panel Leans in Favor Of Engineered Salmon,” by Andrew Pollack, The New York Times, September 21, 2010). “We’re moving too fast,” Goeld continued. “I’m not an expert in biotechnology, but I think many people would like to see thorough studies of the long-term effects genetically engineered salmon will have on real live human beings, and on the natural salmon population.”

Goeld compared Sex, Lies, and Soybeans to Michael Crichton’s “Jurassic Park.” Both books are a mix of fast-paced entertainment and larger-than-life characters with serious messages about genetic engineering, the abuses of big business, and the limitations of government control.

About Rick Goeld

Rick Goeld earned engineering degrees at the Massachusetts Institute of Technology and Northeastern University, and was formerly an executive in the field of high-tech electronics. His first novel, “Searching for Steely Dan,” was published in 2006. He is married, has three grown children, and lives in Scottsdale, Arizona. For more information, visit http://www.SexLiesandSoybeans.com.

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Marketing Expert, Nitin Chhoda, Offers Free Copy of his Bestseller, New and Updated for Physical Therapists Doing Business in 2012

Physical Therapy Marketing

Denville, NJ (PRWEB) February 18, 2012

“The book provides instant access to a done-for-you system to attract physician referrals, flood your practice with 21 new patients and reactivate 87 percent of inactive patients,” said Chhoda.

Chhoda specializes in assisting small practices. He’s aided physical therapy businesses worldwide to implement strategies, techniques and software systems to bring established patients back to the office and attract new clients. The book offers solutions that he uses in his own practice, and those he’s utilized to help client practices increase their profitability.

“Physical Therapy Marketing for the New Economy” provides hundreds of tips and tricks from the world’s premier private practice consultant. Chhoda shatters myths about marketing private practices, getting new patients and gaining control of an unruly practice. The physical therapist brings his considerable experience to bear when addressing website marketing, how to build an enduring rapport with patients, and the role social media plays in small private practices.

Chhoda helps readers identify key leverage points for explosive growth, along with how to use mobile marketing to attract patients and generate referrals from clients and other professionals. The book also reveals Chhoda’s secrets for becoming a celebrity therapist within the community.

Developing people and software systems within the office structure is essential for the smooth operation of any practice. He explores the creation of procedural manuals for when staff are absent, along with systems such as therapy newsletter that offers multiple means of maintaining contact with patients and showcasing practices.

The bestselling book provides detailed information on specializations that will have patients flocking to the office for services and how to keep established patients coming to the office, even in the current economy. Chhoda advises strategies that include consultations and creating urgency with special offers for a limited time, and offers detailed information on how to do so.

Chhoda’s updated strategies for marketing a physical therapist business in 2012 makes use of his many years of experience, while taking into consideration specific challenges of conducting business in the 2012 economy. “Physical Therapy Marketing for the New Economy” offers multiple strategies, options and solutions for increasing profitability, even in an economic climate where the trend is for patients to put off essential services.

Chhoda’s office can be reached by phone at 201-535-4475. For more information or to download the eBook, visit the website at http://www.nitin360.com.

ABOUT NITIN CHHODA

Nitin Chhoda is a licensed physical therapist, a doctor of physical therapy, and a certified strength and conditioning specialist. He’s the author of “Total Activation: The New 5 Step Fitness Mantra” and “Marketing for Physical Therapy Clinics.” He’s been featured in numerous industry magazines, major radio and broadcast media, and is the founder of Referral Ignition training systems, Private Practice Summit, the Private Practice Formula and the Private Practice Mastermind group. Chhoda speaks extensively throughout the U.S., Canada and Asia. He’s the creator of the Therapy Newsletter, along with Clinical Contact, a web-based service that boosts patient arrival rates.

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Bayer CropScience and Texas A&M University System Sign Agreement to Advance Wheat Breeding

Monheim, Germany (PRWEB) February 17, 2012

Bayer CropScience and Texas AgriLife Research, a part of the Texas A&M University System, College Station, Texas, USA have signed a multi-year agreement to develop and commercialize improved wheat varieties. Utilizing Texas AgriLife Research’s extensive collection of wheat cultivars and germplasm and Bayer’s expertise in both classical and molecular plant breeding, the collaboration aims to bolster current development efforts and expedite the delivery of higher yielding wheat varieties to market. Financial details of the collaboration were not released.

In particular, researchers and breeders at both institutions will focus on developing wheat lines that offer improved yields, as well as regionally important characteristics such as drought resistance, disease resistance and improved quality. Texas AgriLife Research is a leading provider of Hard Red Winter Wheat germplasm for the Southern Great Plains region of the U.S., and its collection will serve as a strong basis for developing these new lines.

Additionally, the collaboration will focus on the development of molecular breeding tools to facilitate the rapid genetic improvement of wheat. Combining both classical and modern breeding techniques is expected to increase the rate of wheat yield improvement and allow wheat to thrive in areas with conditions which are unfavorable currently for wheat production.

“Wheat productivity has not kept pace with the advancement in other crops like corn, but Bayer is determined to see that trend reversed,” said Dr. Mathias Kremer, Head of the BioScience business unit at Bayer CropScience. “By working together with the many wheat experts in the Texas A&M University System to harness the tools of modern plant breeding and biotechnology, we are convinced we can help make wheat farmers in Texas and beyond more productive and sustainable by delivering new high-yielding varieties that are more resilient against pests, disease and environmental stresses like drought.”

Dr. Craig Nessler, director of Texas AgriLife Research, said the collaboration with Bayer CropScience will give worldwide exposure to the wheat improvement programs of Texas AgriLife Research and the Texas AgriLife Extension Service. “This endeavor will enhance the impact of these programs while building a strategic research and development relationship with a company that shares AgriLife’s dedication to crop improvement,” Nessler said.

The collaboration with Texas AgriLife Research and the Texas A&M University System is an example of Bayer’s strategy to work with leading global institutions that share a vision of improving wheat productivity in all the major wheat growing regions of the world. This agreement complements the many other collaborations that Bayer has in wheat with organizations including South Dakota State University (USA), University of Nebraska-Lincoln (USA), NARDI (Romania), RAGT (France), Evogene (Israel), and CSIRO (Australia).

TEXAS WHEAT FACTS:

    Texas ranks 4th in production versus other U.S. states.
    Over the past seven years, Texas has averaged planting 5,800,000 acres of winter wheat and harvested about 2,800,000 acres.
    In 2011, about 3.9 million acres across five U.S. states were planted in varieties developed by Texas AgriLife Research.
    Drought tolerance is a key trait of interest in Texas. The 2011 drought devastated the Texas wheat crop, with total production only reaching 49.4 million bushels, compared to 127.5 million bushels in 2010.
    Due to the drought last year, more than 900,000 acres of wheat were abandoned due to extremely poor yield or total crop failure.

About Bayer CropScience

Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience, a subgroup of Bayer AG with annual sales of EUR 6.830 billion (2010), is one of the world’s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of 20,700 and is represented in more than 120 countries. This and further news is available at: http://www.press.bayercropscience.com.

About Texas AgriLife Research/Texas A&M University System

Texas AgriLife Research — the state’s premier research agency in agriculture, natural resources, and the life sciences — is headquartered at Texas A&M University in College Station, but serves the entire state through its on-campus units and regional centers. It is comprised of its College Station headquarters, 13 research centers reaching from El Paso to Beaumont and Amarillo to Weslaco, and associated research stations. A member of The Texas A&M University System, AgriLife Research has 1,600 employees, 500 of which are doctoral-level scientists who are nationally recognized experts in their fields. AgriLife Research collaborates with more than 30 nations. Texas agricultural producers and consumers benefit directly from public investment in agricultural research in the forms of lower consumer prices, improved health and welfare, and an improved environment. Economic gains from investments in Texas’s public agricultural research have reached more than $ 1 billion over the past four decades.

Contact:

Bayer CropScience: Richard Breum, Tel. +49 2173 38-3270

E-Mail: Richard.Breum(at)bayer(dot)com

Texas AgriLife Research: Dr. Craig Nessler, +1 979 845-8486

E-Mail: cnessler(at)tamu(dot)edu

Find more information at http://www.bayercropscience.com.

rib    (2011-0053E)

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at http://www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

# # #

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

States, Federal Government Could Save $ 30 Billion by Managing Medicaid Pharmacy More Like Medicare and Commercial Sector Programs

Washington, DC (Vocus) December 6, 2010

A new study from The Lewin Group finds that Medicaid pharmacy could save more than $ 30 billion over the next decade by transitioning from the current approach used by state Medicaid fee-for-service (FFS) programs to the more efficient approaches used by Medicare Part D plans, Medicaid managed care organizations (MCOs), and the commercial sector, including typical state employee plans.

The study notes that Medicaid FFS pharmacy programs use fewer generic drugs and pay pharmacies higher dispensing fees and ingredient costs than other programs. The findings from this groundbreaking report challenge the assumption that Medicaid pharmacy can only reduce costs by cutting benefits, limiting eligibility, demanding deeper manufacturer rebates, or paying drugstores higher dispensing fees in exchange for more pricing transparency.

“Medicaid is one of the few pharmacy benefit programs that still relies heavily upon a fee-for-service approach. By operating more like Medicare and commercial market plans, Medicaid could increase the use of generics and save billions without cutting benefits,” said Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt.

Currently, three-fourths of Medicaid pharmacy dollars are administered using a fee-for-service approach in which public officials play a role in determining how much to pay drugstores for each prescription filled (dispensing fees) and ingredient costs (the reimbursement for the cost of the actual drugs). The other one-fourth of Medicaid pharmacy is managed more like pharmacy benefits in the commercial sector, where third-parties use proven utilization management tools and negotiate pharmacy payments directly with chain drugstores and the drug wholesalers that represent independent pharmacies.

The Lewin study also finds that although state Medicaid programs pay widely varying Medicaid dispensing fees, these decisions seem largely unrelated to the level of ingredient cost reimbursements a state pays or the level of generic utilization a state achieves. For example, Texas pays the nation’s highest dispensing fees ($ 7.50) and New Hampshire pays the lowest ($ 1.75), but they both pay about the same for ingredient costs and generate similar rates of generic drug utilization.

Many Medicaid pharmacy discussions begin and end with the issue of the drug manufacturer rebates. However, the statutory and supplemental rebates paid to Medicaid by brand name drug manufacturers are determined separately from pharmacy dispensing fees and ingredient costs. This means that manufacturer rebates have no impact on the savings that more active management of dispensing fees and ingredient costs could achieve. Likewise, these savings also do not assume any additional cost sharing for Medicaid beneficiaries.

Key Findings

Savings Opportunities Exist In Four Key Areas

While Medicaid FFS programs and costs vary greatly state-by-state, The Lewin Group identified four key areas where pharmacy benefit management could generally be improved:

Generic Drug Dispensing: Medicaid FFS is less effective at encouraging the dispensing of generic drugs in place of brands. The generic dispensing rate in Medicaid FFS averages 68%, compared to an average 80% generic dispensing rate in Medicaid MCOs.

Dispensing Fees: At $ 4.81 per prescription, the national average dispensing fee that Medicaid FFS programs pay to retail pharmacies per each prescription is more than double the average dispensing fees paid by Medicare Part D payers, Medicaid MCOs, or health plans in the commercial sector.

Ingredient Costs: The rate at which retail pharmacies are reimbursed for the actual medication ingredients (pills, capsules, etc.) is also higher, on average, in Medicaid FFS programs than in Medicare Part D or the commercial sector.

Drug Utilization: The number of prescriptions dispensed per person is typically higher in Medicaid FFS programs than in Medicaid MCOs due to less effective controls on polypharmacy, fraud, waste, abuse, and other factors in the FFS setting.

Estimated Federal and State Medicaid Savings

If all state Medicaid programs used a market-based approach such that dispensing fees, ingredient costs, drug utilization, and generic drug dispensing were brought in-line with norms for Medicaid MCOs, Medicare Part D, and commercial payers, Lewin estimates that:

Combined federal and state savings to the Medicaid program would total $ 30.3 billion over the next decade.
Medicaid FFS prescription costs could be reduced by 14.8%.
Per member per month (PMPM) costs for Medicaid FFS pharmacy benefits could be reduced by $ 12 in 2011 under optimal management.

PCMA represents the nation’s pharmacy benefit managers (PBMs), which improve affordability and quality of care through the use of electronic prescribing (e-prescribing), generic alternatives, mail-service pharmacies, and other innovative tools for 210-plus million Americans.

The full report can be obtained at no charge at http://www.lewin.com/content/publications/Medicaid_Pharmacy_Savings_Report.pdf .

Follow PCMA on Twitter

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

AttorneyOne.com Informs: You Can Still File a Claim and Receive Compensation for Gammagard Side Effects

Gammagard severe adverse effects threat

San Diego, CA (PRWEB) February 10, 2012

The media spotlight is often a double-edged sword. No one knows this better than people who tried Gammagard and experience severe side effects. And yet, gossip and rumor-mongering aside, the real story here is being overlooked, according to Sean Burke of AttorneyOne.

As announced on Jan. 23rd, 2012, Baxter International Inc. provided an update on its clinical program evaluating the use of the Gammagard Liquid for the treatment of mild to moderate Alzheimer’s disease. Additionally, the company plans to initiate a second, confirmatory Phase III trial in the first quarter of 2012.

According to Baxter International Inc. announcement, the second Phase III trial is identical in design to the first Phase III trial, and will assess the safety and effectiveness of Gammagard Liquid as a potential treatment for signs and symptoms associated with Alzheimer’s disease.

At the end of February 1994, Baxter Healthcare announced the removal of Gammagard from the global market because of the possibility that it may have transmitted the hepatitis virus, including hepatitis C. In July 1995, the FDA said that as many as 1,000 cases of hepatitis C could have been linked to use of Gammagard. In September 2000, the U.S.D.C. for the Central District of California approved a settlement of the class action (MDL NO. 95-1060-R) providing financial compensation for U.S. individuals who used Gammagard between January 1993 and February 1994.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal council so that, in case of Gammagard adverse effects, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat of severe adverse effects from Gammagard remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

On May 27th, 2010 Baxter issued a market withdrawal of specific lots of the Gammagard Liquid. The FDA said this voluntary withdrawal was a precautionary measure due to an increased number of adverse effects reports of allergic reactions related to specific lots.

If you have recently been diagnosed with Hepatitis C and you took Gammagard, you might be able to file a Gammagard lawsuit.

AttorneyOne.com has further information on Gammagard lawsuits including how to get in contact with legal council.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. Checkout earlier legal news from us at http://www.prweb.com/releases/2012/2/prweb9175558.htm.

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Asbestos Law Firm Updates Website for Army Veterans Diagnosed with Mesothelioma

(PRWEB) February 09, 2012

Clapper, Patti, Schweizer & Mason (CPSM) urges all U.S. Army veterans diagnosed with mesothelioma, asbestos cancer, or asbestosis to use the resources their law firm offers to help them know the best way to get financial compensation to help pay for their mesothelioma treatments and to provide for their families. The website of CPSM was recently updated to include even more information for Army veterans diagnosed with mesothelioma.

The US Centers for Disease Control (CDC) estimates about 3000 people in the United States will be diagnosed with mesothelioma this year. Of that, about 30% will be veterans from all branches of the military. Although Navy veterans were and are most at risk, Army veterans also have a heightened risk due to the likelihood of exposure to asbestos during service.

Mesothelioma is a fatal cancer that develops in the lining of internal body cavities, such as the heart, lungs, and abdomen, and is caused by exposure to asbestos. Thousands of construction and industrial products were made with asbestos, especially up until the mid-1980’s. These materials, such as asbestos containing insulation, roofing, flooring, wall board and caulking, were then used aboard ships and to construct military housing and mess halls, causing high potential for all those that served in the military, including Navy, Air Force, Marines, Coast Guard and Army, to be at risk of mesothelioma.

CPSM is particularly concerned that Army veterans know they have a right to financial compensation outside of the Veterans Administration (VA). Veterans with asbestos related diseases can file a mesothelioma law suit or asbestos bankruptcy claim against asbestos companies responsible for the products that caused their illness.

The key for Army veterans, or anyone diagnosed with mesothelioma, is to get experienced asbestos attorneys who have expertise in filing claims on behalf of veterans and a long history of winning awards against asbestos manufacturers. CPSM has specialized in assisting veterans diagnosed with mesothelioma for over three decades. Contact CPSM today at 1-800-440-4262 for a free case evaluation or to request a comprehensive brochure explaining your rights, how to file a mesothelioma lawsuit, mesothelioma treatment options, and other support services for those diagnosed with asbestos related illnesses.

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Mesothelioma Victims Center Urges Diagnosed Power Plant & Shipyard Workers To Use Their Unequaled Services That Include The Best Mesothelioma Lawyers & Treatment Options

(PRWEB) February 02, 2012

According to the US Centers for Disease Control, approximately 2500 US citizens will be diagnosed with mesothelioma this year. Of this group, one third will be Veterans of the US Navy. The Mesothelioma Victims Center says, “Easily another third of the people, who will be diagnosed with mesothelioma this year probably worked at a shipyard, a power plant, at an oil refinery, or at a chemical manufacturing facility in the United States. There is a higher incidence of mesothelioma in shipyard, power plant, oil refinery workers, or chemical plant employees, who worked at one of these types of places in the 1940′s, 1950′s, 1960′s, 1970′s, and even the 1980′s because of exposure to asbestos.” The Mesothelioma Victims Centers free services are unsurpassed for any US citizen, who has been diagnosed with mesothelioma cancer. If a mesothelioma victim, or their family is concerned about compensation, as they should be, the Mesothelioma Victims Center is the only group actually offering choices of the best mesothelioma attorneys in the nation. These are all good choices, and all the victim of mesothelioma, or their family have to do is pick the mesothelioma lawyer, or mesothelioma trial law firm they like the best. The group says,”Legal experts have also told us that shipyard, power plant worker, oil refinery, or chemical manufacturing worker mesothelioma lawsuits typically get the best verdicts, and or compensation for the victims. The big if is, do you have the best mesothelioma attorneys? Our service is designed to make certain all US citizens have the absolute best mesothelioma attorneys.” The Mesothelioma Victims Center’s primary goal, and ambition is to make certain victims of mesothelioma, and their family members get the best possible help support, and resources. This goal is also very clearly stated in the Mesothelioma Victims Center Bill Of Rights.

The Mesothelioma Victim Center’s Bill of Rights includes:

The names and specific contacts for the most successful, and reputable mesothelioma attorneys, or mesothelioma trial lawyers in the United States. The Mesothelioma Victims Center says, “There really can be a huge difference between getting a second, or third string mesothelioma personal injury attorney, and or getting the absolute best mesothelioma attorneys in the United States, when it comes to compensation. We recommend, and provide the specific contacts for the best, and the most capable mesothelioma attorneys in the US. No other group offers this vital service.”
A customized mesothelioma cancer treatment options report, that is designed to identify the best mesothelioma cancer treatment options, in the specific area, region, and nation for a victim of mesothelioma.
The Mesothelioma Victims Center will always be on call to any family dealing with mesothelioma. This includes assisting a family with how to live with mesothelioma, assistance with hospice, or any other need they may have. http://MesotheliomaVictimsCenter.Com

Who can get Mesothelioma? Mesothelioma is linked to exposure to asbestos. Individuals who served in the US Navy, or as oil refinery workers, ship yard workers, employees of defense contractors, rail road workers, power plant workers, chemical industry workers, automotive repair specialists, construction workers, plumbers, demolition contractors, were all exposed to asbestos in the 1940′s, 1950′s, 1960′s, 1070′s, and 1980′s. Tragically, one third of all US mesothelioma victims served in the United States Navy, or are US Navy Veterans. The Mesothelioma Victims Center says, “The worst thing about a mesothelioma cancer diagnosis is typically it comes out of the blue. Frequently, an individual served in the US Navy, worked in a power plant, an oil refinery, or a shipyard decades ago, they get pneumonia type symptoms, it does not get better, and in some cases the doctors finally figure out its mesothelioma.” Individuals, or families dealing with a mesothelioma diagnosis, or living with mesothelioma are encouraged to contact the Mesothelioma Victims Center anytime at 866-714-6466 for their unparalleled free services. http://MesotheliomaVictimsCenter.Com

Attachments

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Company Challenges Arthritis Sufferers to Reduce Expenses and Increase Relief

DrunkenRaisins.Com

Lafayette, Colorado (PRWEB) February 01, 2012

In response to the rising cost of prescription medications, a Colorado-based company is challenging people with arthritis to eat a handful of gin-soaked raisins daily.

The invitation isn’t meant to help people forget their pain, even though the thought comes to mind for first-time customers. Instead, it’s a way for arthritis sufferers to try an alternative method of increasing relief from their pain.

Additionally, the recipe is endorsed by Dr. Oz as an approved home remedy for arthritis pain. And it received a 75 percent thumbs-up review from users in an online survey monitored by The People’s Pharmacy.

“Medication and surgery aren’t the only choices for people with arthritis inflammation,” says Larry Wright, DrunkenRaisins founder. “We’re not encouraging people to stop their medications, we’re just asking them to experience what thousands of others swear by as a healthy way of reducing pain.”

And with the price of brand-name prescription medication increasing an overall 7.2 percent in 2011*, the “What Have You Got to Lose” challenge is being met with open arms.

Rather than increasing doses of medicine to keep arthritis pain at bay, DrunkenRaisins users are finding relief by adding eight or nine raisins to their morning oatmeal. “I started this company because gin-soaked raisins gave me so much relief from my own arthritis pain,” says Wright, who added good taste to the age-old folk remedy.

The DrunkenRaisins challenge recommends a three-month trial to cover the range of reported relief time frames by customers. Challenge orders for those first three-pounds of raisins can receive an $ 8.00 discount by them adding the code word “CHALLENGE” to the order.

Developed, produced, packaged and sold from a Lafayette, Colorado location, the updated arthritis pain home remedy is bringing relief to customers worldwide. DrunkenRaisins has been featured in numerous publications as well as on programs like Tom Martino TV and Channel 9 News. For more information or to speak with DrunkenRaisins owner, Larry Wright, please contact Larry; via larry(at)drunkenraisins(dot)com; call 800-461-5949; or go to http://www.drunkenraisins.com.

*According to Barclays Capital

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Gudnason’s Method Shows It Can Cure and Leave Premature Ejaculation In The Past.

(PRWEB) August 5, 2005

Premature Ejaculation is a problem that affects millions of men around the world, converting their love life into a shameful experience instead of an enjoyable part of their lives. Statistics indicate that a great number of these men are afraid of looking for help and even think there is no such help for their condition. But nothing is more distant from the truth. There is help, and recently a new method for helping men with this condition has been released by Christian Gudnason (http://www.askingplanet.com). He has personally helped hundreds of men of all races and walks in life, who often had wasted a great deal of money and time on useless premature ejaculation cures.

This new method has nothing to do with techniques as the application of dangerous desensitizing creams, useless pills or other methods that have barely or never worked for the men that used them. C. Gudnason presents a method that greatly improves over these other techniques and that will take the patient step by step, considering the real origin of the problem, i.e. the mind of the individual. He will give him a set of routines that will result in the premature ejaculation condition totally cured in a few weeks and without the patient feeling his privacy invaded; allowing him to regain his normal sexual life quick and with the confidence that premature ejaculation won’t return. According to Gudnason his method has been successful in 97% of the cases treated, which means more than great odds for those men looking for premature ejaculation cure and who have tried other methods without any results. So, this being said, it seems there is a good reason for million of men to smile tonight.

# # #

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.